首页> 美国卫生研究院文献>Journal of Applied Clinical Medical Physics >Commissioning of the worlds first compact pencil‐beam scanning proton therapy system
【2h】

Commissioning of the worlds first compact pencil‐beam scanning proton therapy system

机译:调试世界上第一台紧凑型笔束扫描质子治疗系统

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This paper summarizes clinical commissioning of the world's first commercial, clinically utilized installation of a compact, image‐guided, pencil‐beam scanning, intensity‐modulated proton therapy system, the IBA Proteus® ONE, at the Willis‐Knighton Cancer Center (WKCC) in Shreveport, LA. The Proteus® ONE is a single‐room, compact‐gantry system employing a cyclotron‐generated proton beam with image guidance via cone‐beam CT as well as stereoscopic orthogonal and oblique planar kV imaging. Coupling 220° of gantry rotation with a 6D robotic couch capable of in plane patient rotations of over 180° degrees allows for 360° of treatment access. Along with general machine characterization, system commissioning required: (a) characterization and calibration of the proton beam, (b) treatment planning system commissioning including CT‐to‐density curve determination, (c) image guidance system commissioning, and (d) safety verification (interlocks and radiation survey). System readiness for patient treatment was validated by irradiating calibration TLDs as well as prostate, head, and lung phantoms from the Imaging and Radiation Oncology Core (IROC), Houston. These results confirmed safe and accurate machine functionality suitable for patient treatment. WKCC also successfully completed an on‐site dosimetry review by an independent team of IROC physicists that corroborated accurate Proteus® ONE dosimetry.
机译:本文总结了在威利斯,世界上第一个商业化,临床上使用的紧凑型,图像引导,笔束扫描,强度调制质子治疗系统IBA Proteus ® ONE的临床调试。路易斯安那州什里夫波特市的奈顿癌症中心(WKCC)。 Proteus ® ONE是一个单室,紧凑型龙门系统,采用回旋加速器产生的质子束,并通过锥束CT进行图像引导,以及立体正交和斜面kV成像。 220°机架旋转与6D机器人卧榻相结合,能够使患者在平面内旋转超过180°,从而可以进行360°的治疗。除了一般的机器表征外,还需要系统调试:(a)质子束的表征和校准;(b)治疗计划系统的调试,包括CT到密度曲线的确定;(c)图像引导系统的调试;以及(d)安全性验证(联锁和辐射调查)。通过照射来自休斯敦成像与放射肿瘤学核心(IROC)的校准TLD以及前列腺,头部和肺部体模,验证了系统为患者准备的就绪状态。这些结果证实了适用于患者治疗的安全,准确的机器功能。 WKCC还由IROC物理学家的一个独立团队成功完成了现场剂量学审查,证实了准确的Proteus ® ONE剂量学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号